Table 1 |
|
|
Levels of Evidence |
|
|
Level I |
Evidence is based on randomized controlled trials (or meta-analysis of such trials) of adequate size to ensure a low risk of incorporating false-positive or false-negative results. |
|
Level II |
Evidence is based on randomized controlled trials that are too small to provide level I evidence. They may show either positive trends that are not statistically significant or no trends and are associated with a high risk of false-negative results. |
|
Level III |
Evidence is based on nonrandomized controlled or cohort studies, case series, case-control studies, or cross-sectional studies. |
|
Level IV |
Evidence is based on the opinion of respected authorities or expert committees as indicated in published consensus conference proceedings or guidelines. |
|
Level V |
Evidence is based on the opinions of those who have written and reviewed the guidelines on the basis of experience, knowledge of the relevant literature, and discussion with peers. |
|
|
|
|
Adapted from Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer: a Canadian consensus document [5]. |
|
|
Becker et al. Allergy, Asthma & Clinical Immunology 2006 2:24 doi:10.1186/1710-1492-2-1-24 |
|